Lescarden Inc.

Lescarden Inc. (Lescarden) is a biotechnology company principally engaged in the development and commercialization of proprietary therapy products with focus basically on clinical skin care, wound healing, osteoarthritis, cancer and autoimmune applications. The company has an extensive research experience of more than five decades in the field of therapeutic applications of cartilage. It markets its lead commercial product, Catrix wound dressing as a powder derived from bovine cartilage that has been shown to be effective in the management of chronic lesions and burns and for non-healing wounds such as decubitus ulcers, venous stasis ulcers, and diabetic ulcers. The company operates in the markets of Canada, Europe, Iceland, Republic of Korea and the US. It is headquartered in New York, the US.